IgA nephropathy: Prognostic classification of end-stage renal failure

Nephrology Dialysis Transplantation

Volumn 12, Issue 12, 1997, Pages 2569-2575

  Frimat, Luc ^a,b   Briançon, Serge ^a   Hestin, Dominique ^a   Aymard, Bernardette ^a   Renoult, Edith ^a   Huu, Thanh Cao ^a   Kessler, Michèle ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b CHU NANCY BRABOIS   (France)

Author keywords

End stage renal failure; IgA nephropathy; Prognostic classification

Indexed keywords

ANTIHYPERTENSIVE AGENT; CREATININE; IMMUNOGLOBULIN A;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; GENDER; HEMATURIA; HIGH RISK POPULATION; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; KIDNEY FAILURE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEINURIA; SCHOOL CHILD; SURVIVAL;

EID: 0030665716     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/12.12.2569     Document Type: Article

References (26)

1. Simon P, Ramée MP, Autuly V et al. Epidemiology of primary glomerular diseases in a French region. Variations according to period and age. Kidney Int 1994; 40: 1192-1198
2. Frimat L, Bellou-Zerrouki M, Kessler M. Incidence annuelle de la néphropathie à IgA (maladie de Berger) et du purpura d'Henoch-Schöenlein dans l'Est de la France. Presse Med 1994; 23: 1879
3. van Ypersele de Strihou C. Fish oil for IgA nephropathy? N Engl J Med 1994, 331: 1227-1229
4. Glassock RJ. IgA nephropathy: report of a symposium down under. Nephrol Dial Transplant 1994; 9: 1341-1343
5. D'Amico G, Minetti L, Ponticelli C et al. Idiopathic IgA mesangial nephropathy. Clinical and histological study of 374 patients. Q J Med 1986; 59: 363-378
6. Beukhof JR, Kardaun O, Schaafsma W et al Toward individual prognosis of IgA nephropathy. Kidney Int 1986; 29: 549-556
7. Alamartine E, Sabatier JC, Guerin C, Berliet JM, Berthoux F. Prognostic factors in mesangial IgA glomerulonephritis: an extensive study with univariate and multivariate analyses. Am J Kidney Dis 1991; 18: 12-19
8. Katafuchi R, Oh Y, Hori K et al. An important role of glomerular segmental lesions on progression of IgA nephropathy: a multivariate analysis. Clin Nephrol 1994; 41: 191-198
9. Ibels LS, Györy AZ. IgA nephropathy: analysis of the natural history, important factors in the progression of renal disease, and a review of the literature. Medicine 1994; 73: 79-102
10. D'Amico G. Influence of clinical and histological features on actuarial renal survival in adult patients with idiopathic IgA nephropathy, membranous nephropathy and membranoproliferative glomemlonephritis: survey of the recent literature. Am J Kidney Dis 1992; 20: 315-323
11. Wasson JH, Sox HS, Neff RK, Goldman L. Clinical prediction rules. N Engl J Med 1985; 313: 793-799
12. Quantin C, Asselain B, Moreau T. Cox's model: limits and extensions. Rev Epidemiol Sante Publique 1990; 38: 341-356
13. Concato J, Feinstein AR, Holford RH. The risk of determining risk with multivariate models. Ann Intern Med 1993; 118: 201-210
14. D'Amico G. Assessment of endpoints in the study of progressive renal disease: summary and concluding remarks. Kidney Int 1994; 45: S132-133
15. Wolfe RA, Strawderman RL. Logical and statistical fallacies in the use of Cox regression models. Am J Kidney Dis 1996; 27: 124-129
16. Lee HS, Koh HI, Lee HB, Park HC. IgA nephropathy in Korea: a morphological and clinical study. Clin Nephrol 1987; 27: 131-140
17. Cox DR. Regression models and life table. J R Stat Soc B 1972; 34: 187-200
18. Moreau T, O'Quigley J, Mesbah M. A global goodness of fit statistic for the proportional hazards model. Appl Stat 1985; 34: 212-218
19. Chastang C, Travade P, Auquier A. Critical discussion of the assessment of a three-stage prognostic classification for chronic lymphocytic leukemia. Stat Med 1985; 4: 287-293
20. BMDP Statistical Software Manual. University Press of California, Los Angeles, 1992
21. Nicholls KM, Fairley KF, Dowling JP, Kincaid-Smith P. The clinical course of mesangial IgA associated nephropathy in adults. Q J Med 1984; 53: 227-250
22. Primat L, Hestin D, Aymard B, Mayeux D, Renoult E, Kessler M. IgA nephropathy in patients over 50 years of age: a multicentre, prospective study. Nephrol Dial Transplant 1996; 11: 1043-1047
23. Rostoker G, Desvaux-Belghiti D, Pilatte Y et al. High-dose immunoglobulin therapy for severe IgA nephropathy and Henoch-Schönlein purpura. Ann Intern Med 1994; 120: 476-484
24. Pettersson EE, Rekola S, Berglund L et al. Treatment of IgA nephropathy with omega-3-polyunsaturated fatty acids: a prospective, double-blind, randomized study. Clin Nephrol 1994; 41: 183-190
25. Donadio JV Jr, Bergstralh EJ, Offord KP, Spencer DC, Holley KE. A controlled trial of fish oil in IgA nephropathy. N Engl J Med 1994; 331: 1194-1199
26. Goumenos D, Ahuja M, Shortland JR, Brown CB. Can immuno-suppressive drugs slow the progression of IgA nephropathy? Nephrol Dial Transplant 1995; 10: 1173-1181